Vitasoy International Holdings Limited (HKG:345) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Shareholders might have noticed that Vitasoy International Holdings Limited (HKG:345) filed its full-year result this time last week. The early response was not positive, with shares down 2.0% to HK$9.15 in the past week. Vitasoy International Holdings reported in line with analyst predictions, delivering revenues of HK$6.3b and statutory earnings per share of HK$0.22, suggesting the business is executing well and in line with its plan. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

Following last week's earnings report, Vitasoy International Holdings' four analysts are forecasting 2026 revenues to be HK$6.31b, approximately in line with the last 12 months. Per-share earnings are expected to surge 22% to HK$0.27. Before this earnings report, the analysts had been forecasting revenues of HK$6.58b and earnings per share (EPS) of HK$0.30 in 2026. It's pretty clear that pessimism has reared its head after the latest results, leading to a weaker revenue outlook and a minor downgrade to earnings per share estimates.

Check out our latest analysis for Vitasoy International Holdings

The analysts made no major changes to their price target of HK$9.97, suggesting the downgrades are not expected to have a long-term impact on Vitasoy International Holdings' valuation. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic Vitasoy International Holdings analyst has a price target of HK$11.66 per share, while the most pessimistic values it at HK$8.80. This is a very narrow spread of estimates, implying either that Vitasoy International Holdings is an easy company to value, or - more likely - the analysts are relying heavily on some key assumptions.

Of course, another way to look at these forecasts is to place them into context against the industry itself. It's also worth noting that the years of declining revenue look to have come to an end, with the forecast stauing flat to the end of 2026. Historically, Vitasoy International Holdings' top line has shrunk approximately 3.6% annually over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenue grow 4.8% per year. Although Vitasoy International Holdings' revenues are expected to improve, it seems that it is still expected to grow slower than the wider industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. On the negative side, they also downgraded their revenue estimates, and forecasts imply they will perform worse than the wider industry. The consensus price target held steady at HK$9.97, with the latest estimates not enough to have an impact on their price targets.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have forecasts for Vitasoy International Holdings going out to 2028, and you can see them free on our platform here.

You can also see our analysis of Vitasoy International Holdings' Board and CEO remuneration and experience, and whether company insiders have been buying stock.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.